Article ID Journal Published Year Pages File Type
3943256 Gynecologic Oncology 2009 5 Pages PDF
Abstract
SHetA2, but not cisplatin or paclitaxel, can overcome resistance of ovarian cancer cells to TNFα and TRAIL without increasing sensitivity of normal cells to these death receptor ligands.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents
Authors
, , ,